Lp(a) Levels in Relatives of Patients with Acute Coronary Syndrome and Elevated Lp(a): HER(a) Study.

Background: Lipoprotein(a) [Lp(a)] is a proatherogenic particle associated with increased cardiovascular risk. It is mainly genetically determined; so, the aim of our study is to evaluate the levels of Lp(a) in the relatives of a prospective cohort of patients who have suffered from an acute coronary syndrome (ACS) with Lp(a) ≥ 50 mg/dL. Methods: We conducted a multicenter prospective study, in which consecutive patients who had suffered from an ACS and presented Lp(a) ≥ 50 mg/dL and their first-degree relatives were included. Results: We included 413 subjects, of which 56.4% were relatives of the patients. Family history of early ischemic heart disease was present in 57.5%, and only 20.6% were receiving statin treatment. The family cohort was younger (37.5 vs. 59.1 years; p < 0.001), and 4% had ischemic heart disease and fewer cardiovascular risk factors. Mean Lp(a) levels were 64.9 mg/dL, 59.4% had levels ≥ 50 mg/dL, and 16.1% had levels ≥ 100 mg/dL. When comparing the patients with respect to their relatives, the mean level of Lp(a) was lower but without significant differences regarding the levels of LDLc, ApoB, and non-HDL. However, relatives with Lp(a) ≥ 50 mg/dL, had values similar to the group of patients with ACS (96.8 vs. 103.8 mg/dL; p = 0.18). No differences were found in Lp(a) levels in relatives based on the other lipid parameters. Conclusions: Overall, 59.4% of the first-degree relatives of patients who suffered from an ACS with Lp(a) ≥ 50 mg/dL also had elevated levels. Relatives with elevated Lp(a) had similar levels as patients.

[Utility of transesophageal echocardiography in young patients with cryptogenic stroke and low cardiovascular risk]. / Utilidad del ecocardiograma transesofágico en pacientes jóvenes con ictus de origen desconocido y bajo riesgo cardiovascular.

BACKGROUND AND OBJECTIVE: Stroke is a high morbimortality disease. In young patients, as many as 40% of acute strokes have no clearly identifiable cause (cryptogenic stroke) and this group of patients had until now limited therapeutic possibilities. However, transesophagical echocardiography (TEE) is changing patient management. PATIENTS AND METHOD: We studied 100 consecutive patients aged 55 years old or less with cryptogenic stroke. TEE was performed in all of them. RESULTS: TEE was normal in 49 patients while in 51 patients it showed any abnormality: patent foramen ovale (PFO) was found in 29 patients, isolated atrial septal aneurysm (ASA) in 1 patient, PFO and ASA in 12 patients, 5 patients had a cardiac mass and in 4 patients we found severe aortic atherosclerotic plaques. Therefore, TEE showed a cardiac source of stroke in 51% of patients. We changed patient management in 46 patients (90.2% of patients with abnormal TEE), indicating percutaneous treatment in 38 patients, surgery in 3 patients and anticoagulant therapy in 5 patients. CONCLUSIONS: TEE found a cardiac cause of stroke in 51% of young patients with cryptogenic stroke. These findings led to change the therapeutic management in 47% of patients. TEE seems to be a useful technique in young patients with cryptogenic stroke.

[Improvement in functional capacity after levothyroxine treatment in patients with chronic heart failure and subclinical hypothyroidism]. / Mejoría de la capacidad funcional tras tratamiento con levotiroxina en pacientes con insuficiencia cardíaca crónica e hipotiroidismo subclínico.

AIM: To assess whether levothyroxine treatment improves functional capacity in patients with chronic heart failure (New York Heart Association class i-iii) and subclinical hypothyroidism. METHODS: One hundred and sixty-three outpatients with stable chronic heart failure followed up for at least 6 months were enrolled. A physical examination was performed, and laboratory tests including thyroid hormone levels, Doppler echocardiogram, radionuclide ventriculography, and Holter monitoring were requested. Functional capacity was assessed by of the 6-min walk test. Patients with subclinical hypothyroidism were detected and, after undergoing the s6-min walk test, were given replacement therapy. When they reached normal thyrotropin (TSH) levels, the 6-min walk test was performed again. The distance walked in both tests was recorded, and the difference in meters covered by each patient was analyzed. RESULTS: Prevalence of subclinical hypothyroidism in patients with heart failure was 13%. These patients walked 292±63m while they were hypothyroid and 350±76m when TSH levels returned to normal, a difference of 58±11m (P<.011). Patients with normal baseline TSH levels showed no significant difference between the 2 6-min walk tests. CONCLUSIONS: Patients with chronic heart failure and subclinical hypothyroidism significantly improved their physical performance when normal TSH levels were reached.

Mejoría de la capacidad funcional tras tratamiento con levotiroxina en pacientes con insuficiencia cardíaca crónica e hipotiroidismo subclínico / Improvement in functional capacity after levothyroxine treatment in patients with chronic heart failure and subclinical hypothyroidism

OBJETIVO: Evaluar si el tratamiento con levotiroxina mejora la capacidad funcional en pacientes con insuficiencia cardíaca crónica clase funcional i-iii de la New York Heart Association e hipotiroidismo subclínico. MÉTODOS: Se incluyeron 163 pacientes ambulatorios con insuficiencia cardíaca crónica estable y con un mínimo de seguimiento de 6 meses. Se realizó un examen clínico y se solicitaron pruebas de laboratorio que incluyeron hormonas tiroideas, ecocardiograma con doppler, ventriculografía radioisotópica y un estudio Holter. La capacidad funcional se evaluó por medio de una caminata de 6min. Se detectaron los pacientes con hipotiroidismo subclínico que recibieron tratamiento sustitutivo y, una vez con valores normales de tirotropina (TSH), se les realizó una nueva caminata de 6min. Se registraron los metros recorridos en cada prueba y se analizó la diferencia de los metros caminados en cada paciente. RESULTADOS: Observamos una prevalencia de hipotiroidismo subclínico del 13% en pacientes con insuficiencia cardíaca. Mientras se encontraban hipotiroideos, los metros recorridos fueron de 292 ± 63, y una vez alcanzados valores normales de TSH, de 350 ± 76. La diferencia en metros fue de 58 ± 11 (p < 0,011). Los pacientes con valores normales de TSH no mostraron diferencias significativas entre las 2 pruebas. CONCLUSIONES: Los pacientes con insuficiencia cardíaca crónica e hipotiroidismo subclínico, una vez eutiroideos, mejoraron de forma significativa su rendimiento físico

AIM: To assess whether levothyroxine treatment improves functional capacity in patients with chronic heart failure (New York Heart Association class i-iii) and subclinical hypothyroidism. METHODS: One hundred and sixty-three outpatients with stable chronic heart failure followed up for at least 6 months were enrolled. A physical examination was performed, and laboratory tests including thyroid hormone levels, Doppler echocardiogram, radionuclide ventriculography, and Holter monitoring were requested. Functional capacity was assessed by of the 6-min walk test. Patients with subclinical hypothyroidism were detected and, after undergoing the s6-min walk test, were given replacement therapy. When they reached normal thyrotropin (TSH) levels, the 6-min walk test was performed again. The distance walked in both tests was recorded, and the difference in meters covered by each patient was analyzed. RESULTS: Prevalence of subclinical hypothyroidism in patients with heart failure was 13%. These patients walked 292 ± 63 m while they were hypothyroid and 350 ± 76m when TSH levels returned to normal, a difference of 58 ± 11 m (P < .011). Patients with normal baseline TSH levels showed no significant difference between the 2 6-min walk tests. CONCLUSIONS: Patients with chronic heart failure and subclinical hypothyroidism significantly improved their physical performance when normal TSH levels were reached

Utilidad del ecocardiograma transesofágico en pacientes jóvenes con ictus de origen desconocido y bajo riesgo cardiovascular / Utility of transesophageal echocardiography in young patients with cryptogenic stroke and low cardiovascular risk

Fundamento y objetivo: El ictus es una enfermedad de gran morbimortalidad. Hasta en un 40% de pacientes jóvenes no se llegaba a conocer la causa (ictus criptogénico) y las posibilidades terapéuticas eran escasas. Sin embargo, la ecocardiografía transesofágica (ETE) y el descubrimiento de nuevas causas de ictus están cambiando la actitud en estos pacientes. Pacientes y método: Se incluyó a 100 pacientes consecutivos de 55 años o menos ingresados en el Servicio de Neurología por ictus criptogénico a los que se les realizó ecocardiografía transtorácica y ETE. Resultados: La edad media (desviación estándar) fue 45,5 (9,7) años. La ETE fue normal en 49 pacientes y patológica en 51: foramen oval permeable (FOP) en 29 pacientes, aneurisma del septo interauricular (ASA) aislado en 1 paciente, FOP asociado a ASA en 12 pacientes, algún tipo de tumoración en 5 pacientes y ateromatosis aórtica de grado avanzado en 4 pacientes. Así, se encontró una causa de ictus en el 51% de los pacientes. Los hallazgos cambiaron la actitud clínica en 46 pacientes (90,2% de las ETE patológicas), por lo que se indicó tratamiento percutáneo en 38 pacientes, cirugía en 3 pacientes y la administración de anticoagulantes orales en 5 pacientes. Conclusiones: La ETE encontró al menos una anomalía que justificara el ictus en el 51% de los pacientes con ictus criptogénico y bajo riesgo cardiovascular. Este hallazgo produjo un cambio en la actitud clínica y terapéutica en el 90% de los pacientes con alguna alteración detectada por ETE. Esta técnica parece de utilidad para el diagnóstico y para la toma de decisiones terapéuticas en estos pacientes

Background and objective: Stroke is a high morbimortality disease. In young patients, as many as 40% of acute strokes have no clearly identifiable cause (cryptogenic stroke) and this group of patients had until now limited therapeutic possibilities. However, transesophagical echocardiography (TEE) is changing patient management. Patients and method: We studied 100 consecutive patients aged 55 years old or less with cryptogenic stroke. TEE was performed in all of them. Results: TEE was normal in 49 patients while in 51 patients it showed any abnormality: patent foramen ovale (PFO) was found in 29 patients, isolated atrial septal aneurysm (ASA) in 1 patient, PFO and ASA in 12 patients, 5 patients had a cardiac mass and in 4 patients we found severe aortic atherosclerotic plaques. Therefore, TEE showed a cardiac source of stroke in 51% of patients. We changed patient management in 46 patients (90.2% of patients with abnormal TEE), indicating percutaneous treatment in 38 patients, surgery in 3 patients and anticoagulant therapy in 5 patients. Conclusions: TEE found a cardiac cause of stroke in 51% of young patients with cryptogenic stroke. These findings led to change the therapeutic management in 47% of patients. TEE seems to be a useful technique in young patients with cryptogenic stroke